Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Podcast
Why Opioid Trends Are Changing in Workers’ Comp
Workers' Comp
Article
Ask The Pharmacist: Biologics and Approved Biosimilar Drugs in Workers’ Compensation
What are biological and biosimilar drugs? It is likely you have heard the terms biological o
Workers' Comp
Case Study
Achieve Operational Excellence
Workers' Comp
Article
Vocational Considerations for Referral to Field Case Management
When physical limitations, education, work history, or job-seeking skills pose a hurdle for injured employees, a field case management referral can
Law.com
Article
Opioids Situation Improves, But Workers’ Comp Pharmacy Faces New Challenges
In workers’ comp pharmacy management, opioids often get the lion’s share of attention, and for good reason.
Risk & Insurance
In the News